Related Experiment Video
Updated: Aug 6, 2026

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
Genetic moderators of naltrexone's effects on alcohol cue reactivity
John E McGeary1, Peter M Monti, Damaris J Rohsenow
1Center for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island 02906, USA. John_McGeary@brown.edu
Background:
Naltrexone (NTX) reduces drinking and craving in alcoholic individuals in treatment and also in heavy drinkers. Polymorphisms in the D4 dopamine receptor (DRD4) gene and mu-opiate receptor gene (OPRM1) may moderate NTX's effects on craving. This study examined these candidate genes as moderators of the effects of NTX on cue-elicited urge to drink in non-treatment-seeking heavy drinkers.
Method:
Data from the subset of 93 participants who consented for genetic testing in a larger study of medication effects were used to examine pharmacogenetic hypotheses. The non-treatment-seeking male and female heavy drinkers (62% alcohol dependent) were genotyped for the variable number of tandem repeats polymorphism in the DRD4 gene [L=7 or more (n=34), S=less than 7 (n=56)] and Asn40Asp single-nucleotide polymorphism in the OPRM1 gene [29 aspartate (Asp) carriers and 59 asparagine (Asn) homozygotes]. Ten days after randomization to NTX (50 mg) or placebo, participants completed an alcohol cue reactivity assessment.
Results:
Any medication effects were all accounted for by interaction with genotype. Naltrexone increased urge for alcohol in Asp carriers across alcohol and neutral beverage cue trials and had no effect on homozygous Asn carriers. Asp40 carriers on either medication had greater decreases (from resting baseline) in mean arterial blood pressure across all beverage cue trials compared with Asn carriers. For DRD4, no differential medication effects by DRD4 polymorphism were found. Alcohol dependence diagnosis did not moderate the effects of gene and medication on cue-elicited measures.
Discussion:
The differential responses to NTX due to variation in the OPRM1 gene may help explain conflicting results in clinical trials and suggest directions for patient-treatment matching.
Insights
Naltrexone’s effect on alcohol craving differs based on OPRM1 gene variations. Asp40 carriers experienced increased urge, while Asn homozygotes showed no change, suggesting personalized naltrexone treatment for heavy drinkers.
Area of Science:
- Pharmacogenetics
- Neuroscience
- Addiction Medicine
Background:
- Naltrexone (NTX) is used to reduce alcohol consumption and craving.
- Genetic variations in dopamine D4 receptor (DRD4) and mu-opiate receptor (OPRM1) genes may influence NTX efficacy.
- This study investigated these genes' role in moderating NTX's effect on alcohol craving in heavy drinkers.
Purpose of the Study:
- To examine if OPRM1 and DRD4 gene polymorphisms moderate the effects of naltrexone on alcohol cue-elicited urge.
- To investigate potential patient-treatment matching strategies for naltrexone therapy.
Main Methods:
- Utilized data from 93 participants in a larger medication study, focusing on those consenting to genetic testing.
- Genotyped participants for DRD4 variable number tandem repeat and OPRM1 Asn40Asp single nucleotide polymorphism.
- Assessed alcohol cue reactivity 10 days after randomization to naltrexone (50 mg) or placebo.
Main Results:
- Naltrexone increased alcohol urge in OPRM1 Asp40 carriers but had no effect in Asn homozygotes.
- Asp40 carriers showed greater decreases in blood pressure compared to Asn carriers.
- No significant effects of DRD4 gene polymorphisms on naltrexone response were observed.
Conclusions:
- OPRM1 gene variation significantly influences individual responses to naltrexone regarding alcohol craving.
- These findings may help reconcile conflicting results from naltrexone clinical trials.
- Highlights the potential for personalized medicine approaches in treating heavy drinking.
More Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
05:40The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
Published on: April 28, 2022
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Drug Abuse and Addiction: Pharmacological Phenomena
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu